Boudoussier, A., Larrouture, I., Henrot, P., Veillon, R., Bardel, C., Chautemps, C., Caumont, C., Schilfarth, P., Duruisseaux, M., Zysman, M. (2025). COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors. Scientific Reports. https://doi.org/10.1038/s41598-025-02251-0